ROE của cổ phiếu HBIO là bao nhiêu?

HARVARD BIOSCIENCE INC có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) -97.39%.

Tỷ suất cổ tức của HBIO là bao nhiêu?

HARVARD BIOSCIENCE INC có tỷ suất cổ tức 0.00%.

Điểm chất lượng (Quality Score) của HBIO là bao nhiêu?

AI của chúng tôi đánh giá chất lượng tài chính tổng thể của HBIO ở mức 46/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.

Bây giờ có nên mua cổ phiếu HBIO không?

Điểm AI Timing của HBIO là 3/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu HBIO thuộc ngành nào?

HARVARD BIOSCIENCE INC được xếp vào ngành Healthcare >> Medical Instruments & Supplies trên sàn NASDAQ

Cổ phiếu HBIO (NASDAQ) | HARVARD BIOSCIENCE INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

HBIO AI Analysis Summary

Our AI summary for HBIO: HARVARD BIOSCIENCE INC (NASDAQ), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 0.00, ROE of -97.39%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 3/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

HBIO

HARVARD BIOSCIENCE INC

USD 6.10

0.01 (0.16%) Day Change

Watchlist Portfolio Compare Chart

3.76

D/E

-97.4%

ROE

-12.6%

ROA

0.00%

Div Yield

HARVARD BIOSCIENCE INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 6.10 Price 0.01 (0.16%) Day Change	NEWS SCORE: 88

HBIO Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) và Thời điểm mua ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...

Yếu tố Chất lượng

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	88
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	6.10
PBV / Sector	2.73 / 3.37
Earning Per Share	-2.17

PE / Sector	N/A / 44.25
PEG or PE/Growth / Sector	N/A / -1.35
Average 1M Daily Value	0.07 M GREAT
Average 1W Daily Value	0.06 M GREAT

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-11.44 / 82.17
NPM Average (%) / Sector	-20.31 / 28.91
NPM Change Average (%) / Sector	145.99 / 208.28 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-12.55 / 7.70
ROA Average (%) / Sector	-20.44 / -22.17
ROA Change Average (%) / Sector	193.16 / 105.15 GREAT
ROE (%) / Sector	-97.39 / 10.10
ROE Average (%) / Sector	-109.53 / 392.40
ROE Change Average (%) / Sector	546.53 / 109.80 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.99
Dividend Average (%) / Sector	N/A / 1.43
Dividend Change Average (%) / Sector	N/A / 11.29

Chi tiết đăng ký

Analyze Date	2026-08-01 07:59:56
Symbol	HBIO
Name	HARVARD BIOSCIENCE INC
Sector	Healthcare >> Medical Instruments & Supplies
Market	NASDAQ
Listed Shares	4.51 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	27.47 / 16,159.14

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 84 October Hill Road, Holliston, MA, United States, 01746

Phone: 508 893 8999

Website: https://www.harvardbioscience.com

Employees: 316

Sector: Healthcare >> Medical Instruments & Supplies

Description: Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.